These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11079487)

  • 1. 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
    Weinmann P; Crestani B; Tazi A; Genereau T; Mal H; Aubier M; Valeyre D; Moretti JL; Le Guludec D; Lebtahi R
    J Nucl Med; 2000 Nov; 41(11):1808-12. PubMed ID: 11079487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumothorax secondary to pulmonary histiocytosis X].
    Bianchi M; Cataldi M
    Minerva Chir; 1999; 54(7-8):531-6. PubMed ID: 10528489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.
    Kahaly G; Diaz M; Hahn K; Beyer J; Bockisch A
    J Nucl Med; 1995 Apr; 36(4):550-4. PubMed ID: 7699440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Langerhans cell histiocytosis lesions with somatostatin analogue scintigraphy--a preliminary report.
    Calming U; Jacobsson H; Henter JI
    Med Pediatr Oncol; 2000 Nov; 35(5):462-7. PubMed ID: 11070478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
    Lee JD; Kim DI; Lee JT; Chang JW; Park CY
    J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic indium-111-pentetreotide scintigraphy in breast cancer.
    Bajc M; Ingvar C; Palmer J
    J Nucl Med; 1996 Apr; 37(4):622-6. PubMed ID: 8691252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
    Nauck C; Ivancević V; Emrich D; Creutzfeldt W
    Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy evaluated in diagnosing and staging Langerhans' cell histiocytosis and related disorders.
    Howarth DM; Mullan BP; Wiseman GA; Wenger DE; Forstrom LA; Dunn WL
    J Nucl Med; 1996 Sep; 37(9):1456-60. PubMed ID: 8790192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favourable outcome of a case of pulmonary Langerhans' cell histiocytosis.
    Miadonna A; Gibelli S; Tedeschi A; Bonelli N; Ferrero S
    Monaldi Arch Chest Dis; 2000 Feb; 55(1):3-5. PubMed ID: 10786415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
    Lebtahi R; Le Cloirec J; Houzard C; Daou D; Sobhani I; Sassolas G; Mignon M; Bourguet P; Le Guludec D
    J Nucl Med; 2002 Jul; 43(7):889-95. PubMed ID: 12097458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor imaging in patients with sarcoidosis.
    Kwekkeboom DJ; Krenning EP; Kho GS; Breeman WA; Van Hagen PM
    Eur J Nucl Med; 1998 Sep; 25(9):1284-92. PubMed ID: 9724378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional imaging of Langerhans cell histiocytosis by (111)In-DTPA-D-Phe(1)-octreotide scintigraphy.
    Lastoria S; Montella L; Catalano L; Rotoli B; Muto P; Palmieri G
    Cancer; 2002 Feb; 94(3):633-40. PubMed ID: 11857294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation pneumonitis imaged with indium-111-pentetreotide.
    Valdés Olmos RA; van Zandwijk N; Boersma LJ; Hoefnagel CA; Baas P; Baars JB; Muller SH; Lebesque JV
    J Nucl Med; 1996 Apr; 37(4):584-8. PubMed ID: 8691245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Caillou B; Fragu P; Parmentier C
    J Nucl Med; 1995 May; 36(5):807-10. PubMed ID: 7738653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
    Asnacios A; Courbon F; Rochaix P; Bauvin E; Cances-Lauwers V; Susini C; Schulz S; Boneu A; Guimbaud R; Buscail L
    J Clin Oncol; 2008 Feb; 26(6):963-70. PubMed ID: 18281671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.
    Breeman WA; Kwekkeboom DJ; Kooij PP; Bakker WH; Hofland LJ; Visser TJ; Ensing GJ; Lamberts SW; Krenning EP
    J Nucl Med; 1995 Apr; 36(4):623-7. PubMed ID: 7699456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
    Leners N; Jamar F; Fiasse R; Ferrant A; Pauwels S
    J Nucl Med; 1996 Jun; 37(6):916-22. PubMed ID: 8683311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult pulmonary Langerhans' cell histiocytosis.
    Tazi A
    Eur Respir J; 2006 Jun; 27(6):1272-85. PubMed ID: 16772390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indium-111-pentetreotide in Graves' disease.
    Kahaly G; Görges R; Diaz M; Hommel G; Bockisch A
    J Nucl Med; 1998 Mar; 39(3):533-6. PubMed ID: 9529305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.